Document 0401 DOCN M9590401 TI Codelivery to mammalian cells of a transcriptional factor with cis-acting element using cationic liposomes. DT 9509 AU Farhood H; Gao X; Barsoum J; Huang L; Department of Pharmacology, University of Pittsburgh, School of; Medicine, Pennsylvania 15261, USA. SO Anal Biochem. 1995 Feb 10;225(1):89-93. Unique Identifier : AIDSLINE MED/95297709 AB The human immunodeficiency virus-1 transactivator protein (tat) was codelivered efficiently with a reporter gene under the control of a tat-responsive DNA element using different formulations of cationic liposomes. Expression of a tat-responsive reporter gene was induced by incubating cells with a mixture of purified recombinant tat protein, reporter DNA, and liposomes. Different cell lines were tested successfully as targets for the codelivery. Tat was shown to trans-activate the codelivered virus promoter specifically in the cells tested. Codelivery of tat with DNA is a useful model for studying the function of trans-acting factors and their cis-acting DNA elements. The currently available methods such as foot-printing only reveal the binding, but not the functional consequence of the binding, of the factor with the element. In addition, this system may prove useful as a model for high level and regulated transgene expression in target cells. DE Animal Base Sequence Carcinoma, Squamous Cell Cell Line Chloramphenicol Acetyltransferase/ANALYSIS/BIOSYNTHESIS Comparative Study CHO Cells Drug Carriers DNA Primers Gene Products, tat/*ADMINISTRATION & DOSAGE/BIOSYNTHESIS Hamsters Hela Cells Human HIV Long Terminal Repeat HIV-1/*METABOLISM Kidney Liposomes Molecular Sequence Data Mutagenesis Phosphatidylethanolamines Plasmids Polymerase Chain Reaction/METHODS Recombinant Proteins/ADMINISTRATION & DOSAGE/ANALYSIS/ BIOSYNTHESIS Sequence Deletion Support, U.S. Gov't, P.H.S. *Trans-Activation (Genetics) Transfection/*METHODS Tumor Cells, Cultured JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).